en

PRODUCT DETAIL

Lenalidomid Teva B.V. 25 mg

Code 9927D
MA number 59/0264/18-S
Product Form: cps dur 7x25 mg (blis.OPA/Al/PVC/Al)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AX Other immunosuppressants
L04AX04 Lenalidomide
Shelf life: 36
Container: blister OPA/Al/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 22.08.2018
Validity: 22.08.2023
PIL: PIL_Lenalidomid Teva B.V._03.2022.pdf  
SPC: SPC_Lenalidomid Teva B.V._04.2022.pdf  
Safety feature Yes
Data update: 23.03.2022
eu-flag.png sk-flag.png